{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T18:19:59Z","timestamp":1773339599279,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"49","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.vaccine.2009.09.014","type":"journal-article","created":{"date-parts":[[2009,9,17]],"date-time":"2009-09-17T09:17:31Z","timestamp":1253179051000},"page":"6824-6832","source":"Crossref","is-referenced-by-count":9,"title":["Modified intra-cerebral challenge assay for acellular pertussis vaccines: Comparisons among whole cell and acellular vaccines"],"prefix":"10.1016","volume":"27","author":[{"given":"R.","family":"Gaines-Das","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Horiuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.M.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Newland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Corbel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.09.014_bib1","unstructured":"Ministry of Health and Welfare, Japanese Government. Minimum Requirements for Biological Products of Japan; 2006:146\u20139."},{"key":"10.1016\/j.vaccine.2009.09.014_bib2","series-title":"The Chinese pharmacopeia","year":"2005"},{"issue":"Suppl. 13","key":"10.1016\/j.vaccine.2009.09.014_bib3","first-page":"79","article-title":"Further characterization of Japanese acellular pertussis vaccine prepared in 1988 by 6 Japanese manufacturers","author":"Sato","year":"1988","journal-title":"Tokai J Exp Clin Med"},{"issue":"Suppl. 13","key":"10.1016\/j.vaccine.2009.09.014_bib4","first-page":"45","article-title":"Overview of currently available Japanese acellular pertussis vaccines and future problems","author":"Kamiya","year":"1988","journal-title":"Tokai J Exp Clin Med"},{"issue":"Suppl. 13","key":"10.1016\/j.vaccine.2009.09.014_bib5","first-page":"39","article-title":"Clinical studies on efficacy and safety of acellular pertussis vaccine","author":"Isomura","year":"1988","journal-title":"Tokai J Exp Clin Med"},{"key":"10.1016\/j.vaccine.2009.09.014_bib6","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1542\/peds.102.3.546","article-title":"Comparative Efficacy of the Lederle\/Takeda acellular pertussis component DTP (DTaP) vaccine and Lederle whole-cell component DTP vaccine in German children after household exposure. Pertussis Vaccine Study Group","volume":"102","author":"Heininger","year":"1998","journal-title":"Pediatrics"},{"issue":"13 Suppl.","key":"10.1016\/j.vaccine.2009.09.014_bib7","first-page":"35","article-title":"Protection against pertussis by Takeda's acellular pertussis vaccine: household contact studies in Kawasaki City, Japan","author":"Kato","year":"1988","journal-title":"Tokai J Exp Clin Med"},{"key":"10.1016\/j.vaccine.2009.09.014_bib8","first-page":"51","article-title":"Clinical trials in the United States and Japan with the Lederle-Takeda and Takeda acellular pertussis-diphtheria-tetanus (APDT) vaccines. The Multicenter APDT Vaccine Study Groups","volume":"73","author":"Cherry","year":"1991","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.vaccine.2009.09.014_bib9","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1086\/515154","volume":"28","author":"Heininger","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2009.09.014_bib10","doi-asserted-by":"crossref","unstructured":"Xing DKL, Corbel MJ, Dobbelaer R, Knezevic I. WHO Working Group on standardisation and control of acellular pertussis vaccines\u2014report of a meeting held on 16\u201317 March 2006. St. Albans, United Kingdom. Vaccine 2007;25:2749\u201357.","DOI":"10.1016\/j.vaccine.2006.09.050"},{"key":"10.1016\/j.vaccine.2009.09.014_bib11","unstructured":"WHO Technical Report Series 897; WHO ECBS 49th Report; 2000."},{"key":"10.1016\/j.vaccine.2009.09.014_bib12","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0092-1157(81)80026-1","article-title":"A collaborative assay of the proposed second International Standard for Pertussis Vaccine and of the proposed first British Standard for Pertussis Vaccine","volume":"9","author":"Seagroatt","year":"1981","journal-title":"J Biol Standardization"},{"key":"10.1016\/j.vaccine.2009.09.014_bib13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1006\/biol.2001.0287","article-title":"Third International Standard for pertussis vaccine: International Confirmation Study of activity of British Standard for pertussis vaccine, coded 66\/303","volume":"29","author":"Xing","year":"2001","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2009.09.014_bib14","unstructured":"WHO study report BS\/88. 1586; 1988."},{"key":"10.1016\/j.vaccine.2009.09.014_bib15","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(88)91778-3","article-title":"Placebo controlled trial of two acellular pertussis vaccines in Sweden: protective efficacy and adverse events","volume":"331","author":"Kallings","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2009.09.014_bib16","series-title":"Statistical method in biological assay","author":"Finney","year":"1978"},{"key":"10.1016\/j.vaccine.2009.09.014_bib17","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0264-410X(01)00372-3","article-title":"Laboratory testing of whole cell pertussis vaccine: a WHO proficiency study using the Kendrick test","volume":"20","author":"Xing","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.014_bib18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/1045-1056(91)90008-8","article-title":"A collaborative assay of the proposed Third British Reference Preparation for Pertussis vaccine and the relative potencies of the second International Standard and the second British Reference Preparation for Pertussis Vaccine","volume":"19","author":"Redhead","year":"1991","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2009.09.014_bib19","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1006\/biol.1996.0051","article-title":"Preparation and standardisation of US Standard Pertussis Vaccine Lot 11","volume":"24","author":"Jansen","year":"1996","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2009.09.014_bib20","unstructured":"WHO study report BS\/06.2036; 2006."},{"issue":"June (6)","key":"10.1016\/j.vaccine.2009.09.014_bib21","first-page":"655","article-title":"Efficacy and immunogenicity of acellular pertussis vaccine by manufacturer and patient age","volume":"143","author":"Aoyama","year":"1989","journal-title":"Am J Dis Child Jun"},{"key":"10.1016\/j.vaccine.2009.09.014_bib22","first-page":"531","article-title":"Clinical efficacy of the Japanese acellular pertuss vaccine after intrafamiliar exposure to pertussis patients","volume":"61","author":"Isomura","year":"1985","journal-title":"Dev Biol Stand"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2009.09.014_bib23","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1442-200X.1989.tb01382.x","article-title":"Protection against pertussis by acellular pertussis vaccines (Takeda, Japan): household contact studies in Kawasaki City, Japan","volume":"31","author":"Kato","year":"1989","journal-title":"Acta Paediatr Jpn"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2009.09.014_bib24","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1017\/S0950268808000708","article-title":"Effectiveness of an acellular pertussis vaccine in Japanese children during a non-epidemic period: a matched case-control study","volume":"137","author":"Okada","year":"2009","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2009.09.014_bib25","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1016\/j.vaccine.2008.04.064","volume":"26","year":"2008","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09013413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09013413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T20:31:22Z","timestamp":1685133082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09013413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":25,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0264410X09013413"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.09.014","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}